Literature DB >> 301505

Complications and immunological studies of measles virus infection in antithymocyte-treated hamsters.

N E Cremer, S J Hagens, D O Taylor, E H Lennette.   

Abstract

A study was done to investigate possible late central nervous system (CNS) complications of latent measles infection in hamsters. Signs of CNS disease, consisting of myoclonus and paralysis, occurred in some weanling hamsters inoculated intraperitoneally at 3 or 9 days of age with antithymocyte serum (ATS) and measles virus, but no late complications in adult life attributable to measles virus were seen. A single series of ATS injections plus an injection of measles virus resulted in sustained antibody formation postulated due to establishment of a latent viral infection, whereas similar treatment with normal rabbit serum plus virus caused no or minimal antibody response. The majority of hamsters receiving ATS as newborns and ATS plus virus as weanlings also did not produce antibody. This differential effect of ATS may be due to combined elimination of suppressor and helper cells in the latter ATS-treated group and of suppressor cells only in the former ATS-treated group. Cellular immunity could not be evaluated since lymphocytes from inoculated and uninoculated hamsters released equal and variable amounts of 51Cr for both infected and noninfected labeled, allogeneic hamster target cells.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 301505      PMCID: PMC421503          DOI: 10.1128/iai.16.1.155-162.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  THE DEVELOPMENT OF A NEUROTROPIC STRAIN OF MEASLES VIRUS IN HAMSTERS AND MICE.

Authors:  T BURNSTEIN; J H JENSEN; B H WAKSMAN
Journal:  J Infect Dis       Date:  1964-06       Impact factor: 5.226

2.  Impaired delayed hypersensitivity in subacute sclerosing panencephalitis.

Authors:  A Klajman; M Sternbach; L Ranon; M Drucker; D Geminder; N Sadan
Journal:  Acta Paediatr Scand       Date:  1973-09

3.  Cytotoxic antibody activity in measles and subacute sclerosing panencephalitis (SSPE) infection.

Authors:  R Kibler; A Deller; V ter Meulen
Journal:  Med Microbiol Immunol       Date:  1974       Impact factor: 3.402

4.  Presence of 2 different viral agents in brain cells of patients with subacute sclerosing panencephalitis.

Authors:  G Barbanti-Brodano; S Oyanagi; M Katz; H Koprowski
Journal:  Proc Soc Exp Biol Med       Date:  1970-05

5.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-04-19       Impact factor: 49.962

6.  Measles and subacute sclerosing panencephalitis.

Authors:  O Kolar
Journal:  Lancet       Date:  1968-12-07       Impact factor: 79.321

7.  Subtle immunologic abnormalities in four boys with subacute sclerosing panencephalitis.

Authors:  K L Gerson; R H Haslam
Journal:  N Engl J Med       Date:  1971-07-08       Impact factor: 91.245

8.  Immunological studies in subacute sclerosing panencephalitis.

Authors:  B Vandvik
Journal:  Acta Neurol Scand       Date:  1970       Impact factor: 3.209

9.  Experimental subacute sclerosing panencephalitis in the hamster: correlation of age with chronic inclusion-cell encephalitis.

Authors:  D P Byington; K P Johnson
Journal:  J Infect Dis       Date:  1972-07       Impact factor: 5.226

10.  Lymphocyte activation in subacute sclerosing panencephalitis virus and cytomegalovirus infections. In vitro stimulation in response to viral-infected cell lines.

Authors:  G B Thurman; A Ahmed; D M Strong; R C Knudsen; W R Grace; K W Sell
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

View more
  2 in total

1.  Cell-mediated cytotoxicity toward measles virus-infected target cells in randomly bred Syrian hamsters.

Authors:  N E Cremer; B O'Keefe; S J Hagens; J Diggs
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

2.  Cytotoxic antibody to cells infected with measles virus in serum and cerebrospinal fluid of multiple sclerosis and control patients.

Authors:  N E Cremer; K P Johnson; G Fein; W H Likosky
Journal:  J Clin Microbiol       Date:  1979-06       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.